Bladder Manager

AOR04445

Helps to relieve urinary incontinence

  • Improves symptoms of urinary incontinence
  • Improves urine flow and ability to fully empty the bladder
  • Helps to reduce symptoms of an overactive bladder
Gluten Free
Non-GMO
Vegetarian

$49.95 or subscribe and save 20%

In stock

Choose a purchase plan:
If you decide a subscription is not for you, it can be cancelled after 30 days.

Urox™ has shown significant reductions of symptoms in both urinary incontinence and stress urinary incontinence and helps in the reduction of nocturia. Made with Crateva magna, Equisetum arvense and Lindera aggregata, the action of these ingredients is used to help treat urolithiasis and as an antioxidant is applicable to many conditions including brain health and fatty liver. Urinary incontinence (UI) is an embarrassing and compelling issue for many people. It affects people of all ages, impacting their quality of life, and complications like an overactive bladder and urinary frequency can arise.

AOR ADVANTAGE

AOR’s Bladder Manager helps improve symptoms of urinary incontinence while reducing the symptoms of an overactive bladder such as daytime urinary frequency in as little as two weeks.

NPN

80101207

Discussion

Helps reduce symptoms of overactive bladder such as daytime urinary frequency, urgency and nocturia (combination of Lindera aggregata, Equisetum arvense and Crateva magna). Helps improve symptoms of urinary incontinence (combination of Lindera aggregata, Equisetum arvense, and Crateva magna).

Guarantee

AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, nuts, peanuts, sesame seeds, sulphites, mustard, dairy, eggs, fish or shellfish.

Adult Dosage

Take two capsules once a day, with food, or as directed by a health care practitioner. Do not open capsules, as this may compromise the stability of the medicinal ingredients. Use for a minimum of eight weeks to see beneficial effects. For prolonged use, consult a health care practitioner.

Cautions

If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. If you are pregnant or breastfeeding, do not use this product. If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of the hands and feet) or are taking diuretics, do not use. Consult a health care practitioner prior to use if you are taking cardiac medications such as cardiac glycosides or antiarrhythmic agents. Stop and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heartbeat and/or difficulty breathing.

Disclaimer

The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.

Serving Size: One Capsules
Crateva magna
120 mg
Equisetum arvense
150 mg
Lindera aggregata
150 mg

Non-medicinal ingredients: rice flour, maltodextrin. Capsule: hypromellose.

Improves symptoms of urinary incontinence

Study #1:
This double blind, placebo controlled study took place over eight weeks and aimed to assess the efficacy of a specialized herbal formula, Urox, versus a control.
This study found that supplementation with Urox led to a lower amount of participants with frequent symptoms of urinary incontinence and well as a lower rate of participants with symptoms of urinary urgency frequency.

https://clinicaltrials.gov/ct2/show/study/NCT02396160

Study #2:

This double blind, placebo controlled trial assessed the efficacy of the herbal combination of Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root in the treatment of symptoms of overactive bladder and urinary incontinence.

One hundred and fifty participants (59% female, aged; mean ± SD; 63.5 ± 13.1 years) took part in the study. At week eight, urinary day frequency was significantly lower (OR 0.01; 95%CI 0.01 to 0.02; p < 0.001) in response to treatment (mean ± SD; 7.69 ± 2.15/day) compared to placebo (10.95 ± 2.47/day). Similarly, episodes of nocturia were significantly fewer (OR 0.03; 95%CI 0.02 to 0.05) after eight weeks of treatment (2.16 ± 1.49/night) versus placebo (3.14 ± 1.36/night). Symptoms of urgency (OR 0.02; 95%CI 0.01 to 0.03), and total incontinence (OR 0.03; 95% CI 0.01 to 0.06) were also lower (all p < 0.01) in the treatment group. Significant improvements in quality of life were reported after treatment in comparison to placebo. No significant side effects were observed resulting in withdrawal from treatment.

https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-018-2101-4

Helps to reduce symptoms of an overactive bladder
This double blind, placebo controlled trial assessed the efficacy of the herbal combination of Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root in the treatment of symptoms of overactive bladder and urinary incontinence.

One hundred and fifty participants (59% female, aged; mean ± SD; 63.5 ± 13.1 years) took part in the study. At week eight, urinary day frequency was significantly lower (OR 0.01; 95%CI 0.01 to 0.02; p < 0.001) in response to treatment (mean ± SD; 7.69 ± 2.15/day) compared to placebo (10.95 ± 2.47/day). Similarly, episodes of nocturia were significantly fewer (OR 0.03; 95%CI 0.02 to 0.05) after eight weeks of treatment (2.16 ± 1.49/night) versus placebo (3.14 ± 1.36/night). Symptoms of urgency (OR 0.02; 95%CI 0.01 to 0.03), and total incontinence (OR 0.03; 95% CI 0.01 to 0.06) were also lower (all p < 0.01) in the treatment group. Significant improvements in quality of life were reported after treatment in comparison to placebo. No significant side effects were observed resulting in withdrawal from treatment.

https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-018-2101-4